메뉴 건너뛰기
Nature Clinical Practice Rheumatology
Volumn 4, Issue 6, 2008, Pages 292-293
A call for pragmatic treatment trials in rheumatoid arthritis
Author keywords

[No Author keywords available]
Indexed keywords

ABATACEPT; CHLOROQUINE; CORTISONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GOLD; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; SALICYLIC ACID;
EID: 44849094402     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0811     Document Type: Article
Times cited : (5)
References (10)
  • 1
    • 38749141455 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis
    • Donahue KE et al. (2008) Systematic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 148: 124-134
    • (2008) Ann Intern Med , vol.148 , pp. 124-134
    • Donahue, K.E.1
  • 2
    • 0030751946 scopus 로고    scopus 로고
    • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    • Boers M et al. (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309-318
    • (1997) Lancet , vol.350 , pp. 309-318
    • Boers, M.1
  • 3
    • 0029053188 scopus 로고
    • The effects of glucocorticosteroids on joint destruction in rheumatoid arthritis
    • for The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group
    • Kirwan JR for The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995) The effects of glucocorticosteroids on joint destruction in rheumatoid arthritis. N Engl J Med 333: 142-146
    • (1995) N Engl J Med , vol.333 , pp. 142-146
    • Kirwan, J.R.1
  • 4
    • 0031990046 scopus 로고    scopus 로고
    • The OMERACT filter for outcome measures in rheumatology
    • Boers M et al. (1998) The OMERACT filter for outcome measures in rheumatology. J Rheumatol 25: 198-199
    • (1998) J Rheumatol , vol.25 , pp. 198-199
    • Boers, M.1
  • 5
    • 0027438710 scopus 로고
    • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha
    • Elliott MJ et al. (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36: 1681-1690
    • (1993) Arthritis Rheum , vol.36 , pp. 1681-1690
    • Elliott, M.J.1
  • 6
    • 2642527933 scopus 로고    scopus 로고
    • Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidity
    • Boers M et al. (2004) Making an impact on mortality in rheumatoid arthritis: Targeting cardiovascular comorbidity. Arthritis Rheum 50: 1734-1739
    • (2004) Arthritis Rheum , vol.50 , pp. 1734-1739
    • Boers, M.1
  • 7
    • 39349086278 scopus 로고    scopus 로고
    • Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
    • MacLean C et al. (2008) Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148: 197-213
    • (2008) Ann Intern Med , vol.148 , pp. 197-213
    • MacLean, C.1
  • 8
    • 0037976830 scopus 로고    scopus 로고
    • Add-on or step-up trials for new drug development in rheumatoid arthritis: A new standard?
    • Boers M (2003) Add-on or step-up trials for new drug development in rheumatoid arthritis: A new standard? Arthritis Rheum 48: 1481-1483
    • (2003) Arthritis Rheum , vol.48 , pp. 1481-1483
    • Boers, M.1
  • 9
    • 0003177157 scopus 로고    scopus 로고
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
    • The European Parliament and the Council of the European Union
    • The European Parliament and the Council of the European Union (2001) Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities L 121 44: 34-44
    • (2001) Official Journal of the European Communities L , vol.121 , Issue.44 , pp. 34-44
  • 10
    • 37149040084 scopus 로고    scopus 로고
    • It is the best of times; it is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues
    • O'Dell JR (2007) It is the best of times; it is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues. Arthritis Rheum 56 3884-3886
    • (2007) Arthritis Rheum , vol.56 , pp. 3884-3886
    • O'Dell, J.R.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.